Study protocol for randomised clinical trial comparing the effectiveness of side-lying sleep positioning to back-lying at reducing oxygen desaturation resulting from obstructive sleep apnoea in infants with cleft palate (SLUMBRS2).


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
07 04 2021
Historique:
entrez: 8 4 2021
pubmed: 9 4 2021
medline: 21 5 2021
Statut: epublish

Résumé

The craniofacial abnormalities found in infants with cleft palate (CP) decrease their airway patency and increase their risk of obstructive sleep apnoea (OSA). We hypothesise that optimising sleep position in infants with CP may improve airway patency and offer a 'low-cost, high-impact' intervention to prevent the negative impacts of OSA. Because cleft centres give inconsistent advice about sleep position: some recommend back-lying and others side-lying, we will compare these in a randomised controlled trial. The aim is to determine the clinical effectiveness of side-lying as compared with back-lying sleep positioning in terms of reducing oxygen desaturation resulting from OSA in 244 infants aged 3-5 weeks of age, diagnosed with an isolated CP in/by UK cleft centres. Primary outcome is the 4% Oxygen Desaturation Index measured using pulse oximetry during sleep. 1. Multicentre randomised controlled trial of side-lying compared with back-lying sleep positioning in reducing oxygen desaturation resulting from OSA in infants with CP at one month of age. 2. Internal pilot questionnaire-based study to support parents and clinicians regarding study participation, seeking to identify and address any barriers to recruitment. Monitoring data from the internal pilot will be used in the final analysis. 3. Co-development of new UK recommendations with Cleft Lip and Palate Association (CLAPA) regarding sleep position for infants with CP. The study protocol has received the favourable opinion of the West Midlands-South Birmingham Research Ethics Committee. Study results will be published on affiliated webpages and in peer-reviewed publications and conference contributions. NCT04478201.

Identifiants

pubmed: 33827851
pii: bmjopen-2021-049290
doi: 10.1136/bmjopen-2021-049290
pmc: PMC8031693
doi:

Substances chimiques

Oxygen S88TT14065

Banques de données

ClinicalTrials.gov
['NCT04478201']

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e049290

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Cleft Palate Craniofac J. 2009 Mar;46(2):117-23
pubmed: 19254061
Anesth Analg. 2004 Dec;99(6):1638-41, table of contents
pubmed: 15562046
Cleft Palate Craniofac J. 2021 Apr 1;:10556656211003459
pubmed: 33792409
J Paediatr Child Health. 2019 Oct;55(10):1279
pubmed: 31629377
Anesthesiology. 2005 Sep;103(3):484-8
pubmed: 16129971
BMJ. 2013 Jan 08;346:e7586
pubmed: 23303884
Br J Plast Surg. 2001 Sep;54(6):471-5
pubmed: 11513506
Laryngoscope. 2008 Jan;118(1):120-3
pubmed: 17975504
Pediatr Pulmonol. 2008 Mar;43(3):245-50
pubmed: 18219693
Anesth Analg. 2005 Apr;100(4):949-52
pubmed: 15781504
J Clin Epidemiol. 2010 Aug;63(8):e1-37
pubmed: 20346624
Clin Plast Surg. 2014 Apr;41(2):189-210
pubmed: 24607188
J Pediatr. 1999 Nov;135(5):580-6
pubmed: 10547246
Sleep Med. 2006 Apr;7(3):211-9
pubmed: 16564742
Eur J Pediatr. 2017 May;176(5):661-667
pubmed: 28331972
Arch Dis Child. 2018 Sep;103(9):868-872
pubmed: 29574409
Cleft Palate Craniofac J. 2019 Feb;56(2):222-230
pubmed: 29665338
Am J Orthod Dentofacial Orthop. 2002 Aug;122(2):189-94; discussion 194-5
pubmed: 12165773
Arch Dis Child. 2012 Dec;97(12):1058-63
pubmed: 23042804
Acta Paediatr. 2000 Nov;89(11):1284-9
pubmed: 11106037
Anesth Analg. 2007 Jun;104(6):1352-5, table of contents
pubmed: 17513625

Auteurs

Aleksandra Metryka (A)

Research and Innovation, Manchester University NHS Foundation Trust, Manchester, Manchester, UK.

Claire Cuniffe (C)

Cleft Lip and Palate Association (CLAPA), London, UK.

Hazel J Evans (HJ)

Department of Respiratory Paediatrics, Southampton Children's Hospital, Southampton, UK.

Johanna G Gavlak (JG)

Department of Respiratory Paediatrics, Southampton Children's Hospital, Southampton, UK.

Nichola Hudson (N)

Salisbury NHS Foundation Trust, Salisbury, Wiltshire, UK.

Nigel Kirby (N)

Centre for Trials Research, Cardiff University, Cardiff, UK.

Monica Lakhanpaul (M)

Policy & Practice Department, UCL Great Ormond Street Institute of Child Health Population Policy and Practice, London, UK.
Community Paediatrics, Whittington Health NHS Trust, London, UK.

Yin-Ling Lin (YL)

School of Dentistry, The University of Manchester, Manchester, UK.

Clare Murray (C)

Royal Manchester Children's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Division of Infection, Immunity and Respiratory Medicine, The University of Manchester Faculty of Biology Medicine and Health, Manchester, Manchester, UK.

Azita Rajai (A)

Research and Innovation, Manchester University NHS Foundation Trust, Manchester, Manchester, UK.

Helen Robson (H)

Royal Manchester Children's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

Anne Schilder (A)

evidENT, UCL Ear Institute, London, UK.
NIHR University College London Hospitals Biomedical Research Centre, London, UK.

Tanya Walsh (T)

School of Dentistry, The University of Manchester, Manchester, UK.

Iain Bruce (I)

Royal Manchester Children's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK iain.bruce@manchester.ac.uk.
Division of Infection, Immunity and Respiratory Medicine, The University of Manchester Faculty of Biology Medicine and Health, Manchester, Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH